Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,724 public trials 629 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)

NCT05243680

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Lancaster, California, United States
  • GSK Investigational Site Colorado Springs, Colorado, United States
  • GSK Investigational Site Lafayette, Colorado, United States
View all 137 locations
View Trial Details
Completed

Evaluation of 611(Recombinant Humanized Anti-interleukin-4 Receptor Alpha IgG4 Monoclonal Antibody) in Chinese Adults With Moderate to Severe Atopic Dermatitis

NCT06173284

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
Locations
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Dermatology Hospital of Jiangxi Province Nanchang, Jiangxi, China
  • Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
  • The Fourth Affiliated Hospital Zhejiang University School of Medicine Jinhua, Zhejiang, China
View Trial Details
Completed

Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

NCT03422822

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Total Skin and Beauty Dermatology Center, PC Birmingham, Alabama, United States
  • Clinical Research Center of Alabama, LLC Birmingham, Alabama, United States
  • University of Alabama at Birmingham - Dermatology Research Clinic Birmingham, Alabama, United States
  • University of Alabama at Birmingham Hospital Outreach Lab Birmingham, Alabama, United States
View all 539 locations
View Trial Details
Completed

Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma

NCT05251259

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Sheffield, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Tucson, Arizona, United States
View all 234 locations
View Trial Details
Completed

Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma

NCT03226392

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Novartis Investigative Site Andalusia, Alabama, United States
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Tucson, Arizona, United States
  • Novartis Investigative Site Los Angeles, California, United States
View all 142 locations
View Trial Details
Completed

Study to Investigate the Efficacy and Safety of QGE031 in Adolescent Patients With Chronic Spontaneous Urticaria (CSU)

NCT03437278

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Novartis Investigative Site Rosario, Santa Fe Province, Argentina
  • Novartis Investigative Site Bahía Blanca, Argentina
  • Novartis Investigative Site Buenos Aires, Argentina
  • Novartis Investigative Site Brussels, Belgium
View all 20 locations
View Trial Details

Related conditions